Stockscreener 앱 받기
14.70
2.53%
-0.4293
Relay Therapeutics Inc 주식(RLAY)의 최신 뉴스
Relay Therapeutics advances zovegalisib combo in breast cancer - TipRanks
Relay Therapeutics (Nasdaq: RLAY) plans Phase 3 breast cancer trial for zovegalisib - Stock Titan
Breast cancer combo posts 44% response in pretreated patients - Stock Titan
Relay Therapeutics Announces Clinical Data for Zovegalisib - GlobeNewswire
Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN
Industry Analysts Just Upgraded Their Relay Therapeutics, Inc. (NASDAQ:RLAY) Revenue Forecasts By 57% - Moomoo
RLAY SEC FilingsRelay Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
RLAY PE Ratio & Valuation, Is RLAY Overvalued - Intellectia AI
Relay Therapeutics (RLAY) Stock: Is It a Good Buy | Q4 2025: EPS Beats ForecastsReal-time Trade Ideas - UBND thành phố Hải Phòng
Is Relay Therapeutics (RLAY) stock strengthening its trend | Q4 2025: EPS Beats ForecastsCommunity Buy Alerts - Cổng thông tin điện tử Tỉnh Sơn La
JonesResearch Initiates Coverage of Relay Therapeutics with Hold Rating - HarianBasis.co
Relay Therapeutics (RLAY) climbs 16% ahead of cancer treatment update - MSN
Is Relay Therapeutics (RLAY) stock gaining momentum (Mini Selloff) 2026-04-20Fast Moving Stocks - Xã Vĩnh Công
JonesResearch Initiates Coverage of Relay Therapeutics (RLAY) With a Hold Rating - Insider Monkey
Relay Therapeutics (RLAY) Stock: Stability Assessment (Buying Pressure) 2026-04-18Intraday Trading - Cổng thông tin điện tử Tỉnh Sơn La
5 Best Low Priced Biotech Stocks to Invest In - Insider Monkey
Tudor Investment Corp ET AL Acquires New Shares in Relay Therapeutics, Inc. $RLAY - MarketBeat
PERCEPTIVE ADVISORS LLC Significantly Reduces Stake in Relay The - GuruFocus
[PRE 14A] Relay Therapeutics, Inc. Preliminary Proxy Statement - Stock Titan
Jones Trading initiates coverage of Relay Therapeutics (RLAY) with hold recommendation - MSN
Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year HighShould You Buy? - MarketBeat
RLAY Initiated Coverage by Jones Trading -- Rating Set to Hold - GuruFocus
JonesTrading Initiates Coverage on Relay Therapeutics (NASDAQ:RLAY) - MarketBeat
Perceptive Fund (RLAY) reports 9.99% ownership — 438,471 shares - Stock Titan
Will Relay Therapeutics (RLAY) Stock Recover Soon | Price at $15.21, Up 1.81%Price Target - UBND thành phố Hải Phòng
Relay Therapeutics CFO Sells $27,000 in Stock - National Today
Relay Therapeutics CFO Sells $27,000 in Shares - National Today
Relay Therapeutics stock hits 52-week high at 14.98 USD By Investing.com - Investing.com Canada
Relay Therapeutics Hits New 52-Week High After Analyst Upgrade - National Today
Earnings Recap: Will Relay Therapeutics Inc benefit from green energy policies2026 Action & Reliable Entry Point Alerts - baoquankhu1.vn
Catinazzo, Relay Therapeutics CFO, sells $257k in RLAY stock By Investing.com - Investing.com Australia
Catinazzo, Relay Therapeutics CFO, sells $257k in RLAY stock - Investing.com
Thomas Catinazzo Sells 1,800 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Relay Therapeutics (NASDAQ: RLAY) CFO logs 19,517-share sale under 10b5-1 plan - Stock Titan
Rally Mode: Will Relay Therapeutics Inc benefit from government policyRate Cut & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Relay Therapeutics stock hits 52-week high at 14.98 USD - Investing.com
1.73%
2.52%
자본화:
|
볼륨(24시간):